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Abstract 
Background: Follicular dendritic cells (FDCs) are important components in the organization of germinal centers in 
lymphoid tissue where, following antigen presentation, B cells differentiate into memory B cells. The possibility of 
establishing primary cell lines from FDCs isolated from lymphoid tissue paved the way for characterization of FDC 
biological properties. We exposed primary FDC cell lines to HIV‑1 strains in vitro and studied changes in the chemo‑
attractive properties of FDCs and release of inflammatory cytokines.
Results: FDC lines expressed several known and putative HIV‑1 receptors; viral genome was amplified in HIV‑1 
exposed FDCs which released low levels of p24 HIV‑1 protein in culture supernatants, but were not definitely proven 
to be productively infected. Exposure of FDCs to HIV‑1 strains did not change the expression of markers used to 
characterize these cells. HIV‑1 exposed FDCs, however, changed the expression of chemo‑attractants involved in cell 
recruitment at inflammatory sites and increased the production of several inflammatory cytokines. The inflammatory 
milieu created upon HIV‑1 exposure of FDCs led to impaired B cell survival in vitro and reduced Ig production.
Conclusions: FDC lines exposed to different HIV‑1 strains, although not able to support productive HIV‑1 replication, 
show an increased production of inflammatory cytokines. Our in vitro model of interactions between HIV‑1 exposed 
FDC lines and B cells suggest that exposure of FDCs to HIV‑1 in vivo can contribute to inflammation within germinal 
centers and that this pathological event may impair B cell survival and contribute to impaired B cell responses during 
HIV‑1 infection.
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Background
Follicular dendritic cells (FDCs) are unique to primary 
and secondary lymphoid follicles and comprise the best 
defined stromal cell subset [1]. The origin of FDCs is 
uncertain; some studies suggest that these cells have 
stromal and mesenchymal origin and most likely emerge 
from ubiquitous perivascular precursors [2, 3] while 
another report, basing on the antigenic phenotype of 
FDCs, related their origin to bone marrow stromal cell 
progenitors and myofibroblasts [4].
FDCs are important components in the organization 
of the germinal centre (GC) microarchitecture through 
an elaborated physical interplay with B cells. The major 
function of FDCs within the GC microenvironment is 
to present unprocessed antigen in the form of immune 
complexes (ICs) to B cells and to provide chemokines, 
adhesion molecules and trophic factors to shape adaptive 
B cell responses. Stationary FDCs attract motile CXCR5+ 
B cells into the secondary lymphoid organs by providing 
them with B cell chemo-attractants including CXCL13 
[2]. B cells, in turn, are essential for FDC development 
and maintenance through the production of lymphotox-
ins (LFs) and, to a lesser extent, tumor necrosis factor 
(TNF). The absence of B cells, or of either LTs or TNF 
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in lymphoid organs results in lack of FDC formation, as 
demonstrated in murine models [5–7].
FDCs have a unique ability to trap ICs in B cell folli-
cles over a long period of time [7, 8]. Presentation of anti-
gen at the surface of FDCs is critical for clonal selection 
and affinity maturation of activated B cells. The FDC-IC 
complex stimulates cognate follicular B cells via the B 
cell receptor, and provides additional signals through the 
complement and FC receptors. The role that FDCs have 
in the generation of memory B cells has progressively 
become evident.
FDCs are major reservoirs for HIV-1 within the lymph 
nodes of infected patients [9, 10]. Highly infectious 
HIV-1 virions coated with HIV-1 antibodies are trapped 
on the processes of FDCs [11]. In addition to their role as 
important reservoirs of infectious virus, FDCs can con-
tribute to increased HIV-1 production in the lymphoid 
tissue microenvironment through a soluble TNF-α medi-
ated mechanism [12].
The expression of potential HIV-1 receptors on FDCs 
has been poorly characterized and the possibility that 
these cells may become the target of productive HIV-1 
infection has not been conclusively ruled out. To achieve 
attachment to CD4+ T cells, HIV-1 binds primarily to 
its main receptor, the CD4 molecule, and to at least one 
of its co-receptors, the CXCR4 or CCR5 chemokine 
receptors. Several other molecules have, however, been 
shown to act as potential HIV-1 receptors in the context 
of HIV-1 infection of several cell types in vitro but their 
significance in  vivo is uncertain. The HIV-1 envelope 
protein gp120 can bind to the activated form of the inte-
grin α4β7 on CD4+ T lymphocytes [13]. Moreover HIV-1 
has the ability to attach to the Sialic acid-binding Ig-like 
lectin 1 (Siglec-1), the TAM receptors on dendritic cells 
(DCs) and the DC specific ICAM-3 grabbing non inte-
grin (DC-SIGN) on DCs and B-cells [14–16]. The criti-
cal role of CD21 in HIV-1 trapping by cells in the lymph 
nodes was shown in a murine study [17].
Several phenotypic and functional abnormalities have 
been described to affect B cells during HIV-1 infection. 
The frequency of resting memory B cells is reduced in the 
peripheral blood of HIV-1 infected adults and children 
[18–20] and antiretroviral therapy initiated in patients 
with chronic HIV-1 infection does not restore the physi-
ological levels of memory B cells [21]. The reduced 
number of resting memory B cells may be one of the 
underlying causes for the poor response to vaccines and 
declined serological memory in HIV-1 infected individu-
als [22].
FDCs play an important role for instructing the molec-
ular contact between T and B cells within the GCs and it 
is therefore reasonable to ask whether B cell dysfunctions 
during HIV-1 infection may be initiated in the context of 
GC formation. In monkeys infected with simian immu-
nodeficiency virus (SIV) and rapidly progressing to dis-
ease, disruption of the FDC network in the GCs could be 
monitored early following infection, together with pro-
gressive depletion of proliferating B cells [23]. Interest-
ingly, no obvious depletion of peripheral CD4+ T cells 
was observed in these monkeys while a high frequency 
of productively SIV infected cells and large amounts of 
accumulated viral RNA were evident in the GCs [23].
For many years it has been difficult to conduct in vitro 
studies with FDCs, partly because of the difficulty in 
obtaining a large number of these cells which exists at a 
low proportion in lymphoid tissues, representing only 
1  % of cells in this compartment. Another limiting fac-
tor in establishing FDC cultures from lymphoid tissue 
is the presence of B cells tightly entrapped in FDC den-
dritic processes. The definition of immune alterations 
which may take place in the FDCs as result of HIV-1 
infection require additional studies. In the present work 
we exposed primary FDC lines [4] to HIV-1 in vitro and 
studied whether, upon this condition, changes in the 
biology of FDCs took place which could affect migra-
tion and survival of B cells, mimicking events which 
commonly take place in the GC between FDCs and 
B cells. The results show that FDC lines are unlikely to 
be directly infected and to support HIV-1 replication. 
HIV-1 exposed FDCs, however, changed the expression 
of chemo-attractants and increased the production of 
several inflammatory cytokines, conditions which caused 
impaired B cell survival and declined Ig production.
Results
The phenotype of HIV‑1 exposed FDCs is comparable 
to non‑exposed cells
We aimed at studying whether exposure of FDCs to 
HIV-1 could modify the antigenic profile of FDCs. For 
the purpose, four FDC lines (1401, 1402, 1403, 8–13) 
were characterized for phenotypical markers previously 
associated with FDCs [4]: CD10, CD14, CD31, CD35, 
CD45, CD54 or ICAM-1, CD90, CD106 (or VCAM-1), 
CD140B, CD146, ASMA, HLA-DR, MFGE8 and Podo-
planin. In addition, the expression of molecules involved 
in the interaction of FDCs with B and T-cells, includ-
ing CD44 [24], CD105 [25], CXCL12 [26] and CXCL13 
[27] were also assessed on FDCs. The gating strategy for 
selection of CXCL12 and MFGE8 positive cells in the 
FDC line 1403, exposed or not to HIV-1 strains IIIB and 
SF162, is shown in Additional file 1: Figure S1.
FDC cultures exposed for 3 days to the HIV-1 strains 
IIIB and SF162, or to medium, showed comparable 
expression of CD10, CD14, CD44, CD54, CD90, CD105, 
CD106, CD140B, CXCL12, ASMA, HLA-DR and 
MFGE8 (Fig. 1). The expression of HLA-DR and MFGE8 
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Fig. 1 Expression of surface markers on HIV‑1 exposed FDCs. The expression of characteristic FDC markers was measured by flow cytometry in FDC 
lines 1401, 1402, 1403 and 8–13 at 3 days post exposure to either IIIB or SF162 HIV‑1 strains, or control medium. Bars represent the percentage of 
positive cells in FDC lines. Exposure to HIV‑1 did not change significantly the phenotypic characteristics of FDCs
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remained stable after HIV-1 exposure but differed 
between the individual FDC lines (Fig. 1). The expression 
of podoplanin and CXCL13 remained stable in 3 of the 4 
lines analyzed following exposure to HIV-1 strains (lines 
1401, 1402, and 1403 for podoplanin and lines 1401, 1402 
and 8–13 for CXCL13). However in the FDC line 1403, 
CXCL13 expression was reduced following exposure to 
HIV-1 strains IIIB and SF162 (from 65 to 29 and 23 %); in 
addition the expression of podoplanin was reduced once 
the cells were exposed to IIIB strain, but not when the 
cells where exposed to SF162 (from 93 to 53 and 84 %). 
The expression of CD31, CD35, CD45 and CD146 was 
maintained stably negative following exposure to HIV-1 
in all four lines as shown in Fig. 1. Taken together, these 
results show that exposure to HIV-1 does not alter signif-
icantly the phenotypical characteristic of FDCs in vitro.
Exposure of FDC lines to HIV‑1 strains
Three primary FDC lines (8–13, 9–13 and 10–13) were 
characterized for the expression of potential HIV-1 
receptors and co-receptors. Flow cytometry analy-
sis demonstrated the consistent expression of sev-
eral potential HIV-1 receptors on FDCs cells: CD4 
(expressed on 7.1  %  ±  5 of FDCs), CD21 (17.9  ±  3.2), 
Siglec 1 (8.8 % ± 2), TAM Axl (1.4 % ± 0.8), TAM Mer 
(8.5  % ±  0.09), Dtk Mer (11  % ±  14.2), low expression 
of CXCR4 (0.78 % ± 0.35) and no expression of the two 
components of the α4β7 Integrin, DC-SIGN and CCR5 
(Fig.  2a). The gating strategy for detection of CD4 and 
CCR5 molecules on the 9–13 line is shown in Additional 
file 2: Figure S2.
The interaction of HIV-1 with FDCs has been described 
to be limited to capture of the virus by FDCs through 
immune complexes; whether HIV-1 can directly infect 
and replicate in FDCs has been poorly studied. HIV-1 
pol sequences were detected in DNA and RNA extracted 
from FDCs exposed for 7  days to IIIB or SF162 HIV-1 
strains, but not in cells cultured in medium (Fig. 2b).
Low levels of HIV-1 p24 were detectable in the super-
natant of all three FDCs lines exposed to HIV-1 for 
10 days as compared to the non-exposed lines. The p24 
absorbance values detected by ELISA were low but above 
the cut-off absorbance value of 0.28 (Fig. 2c). Virus was 
detected in the supernatants of IIIB exposed FDCs 1401 
and 1403 (absorbance 0.44 and 0.48) and in the SF162 
exposed FDC line 1402 (absorbance 0.57).These observa-
tions suggest that a low productive HIV-1 infection may 
take place in FDCs in vitro.
In order to further study if FDC cell lines were pro-
ductively infected we performed kinetics experiments 
of p24 release into culture supernatants (Fig.  3a) and 
HIV-1 RNA (not shown) and also stained FDC cells 
for intracellular p24 production (Fig.  3b). Production 
of p24 in culture supernatant of FDC lines 8–13 and 
10–13 exposed to IIIB and SF162 isolates was followed 
for 2  weeks; the results of this experiment showed that 
a minimal level of p24 production could be detected in 
cultures exposed to the two HIV-1 strains between 3 and 
7  days post-infection (Fig.  3a). Intracellular p24 detec-
tion at 7 days post-infection showed a similar low num-
ber of p24 positive cells in 8–13 and 10–13 FDC cultures 
exposed to strains IIIB and SF162 as compared to cul-
tures grown in medium (Fig. 3b).
HIV-1 RNA was quantified in supernatants of FDC 
lines 8–13 and 10–13 exposed to IIIB and SF162 at day 0 
of infection and at 7 days post-infection. The specimens 
at day 0 were collected after over-night incubation of the 
virus with FDC cultures, following extensive washings. 
A semi-quantitative PCR method revealed that HIV-1 
RNA was detectable in culture supernatants at dilutions 
between 1:10 and 1:100 (results not shown) and that the 
RNA levels did not significantly increase between days 
0 and 7 from infection. These experiments support the 
scenario that only few HIV-1 infected cells are present in 
FDC cell cultures exposed to HIV-1 strains and that the 
frequency of infected cells does not increase over-time.
Altogether the experiments indicate that HIV-1 strains 
do not establish a clearly detectable productive infection 
in FDC lines. For this reason, we will use the terminology 
“exposed” when referring to FDC lines incubated with 
virus.
mRNA expression of chemokines and chemokine receptors 
in HIV‑1 exposed FDCs
To study whether HIV-1 infection impacts on the chemo-
tactic and migratory capacity of FDCs cells, we analyzed 
mRNA expression of chemokines and chemokine recep-
tors in IIIB and SF162 exposed and control FDCs. We 
analyzed 84 genes that encode for human chemokines 
and chemokine receptors in FDC lines 8–13, 9–13 and 
10–13 at day 2 post-virus exposure. Figure  4 illustrates, 
both in fold changes and as heat maps, the genes which 
expression was dysregulated upon HIV-1 infection. A 
significant up-regulation (>2 fold changes, p  <  0.05) of 
genes encoding for CCL2, CXCL3 and IL-8 was observed 
in the FDC lines exposed to both IIIB and SF162 HIV-1 
strains (Fig. 4a, b), as compared to FDC lines treated with 
culture medium. The gene expression of the chemokine 
ligand CXCL5 was up-regulated only in IIIB exposed 
FDCs, while an increased expression of CMTM4 and 
CXCL6 genes was revealed in SF162 exposed cells 
(Fig.  4). Among the down-regulated genes, the expres-
sion level of CCL25 was decreased more than twofold 
(p < 0.05) in SF162 exposed cells while a down-regulation 
of IL-4 gene expression was detected in both IIIB and 
SF162 exposed FDCs.
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Fig. 2 Exposure of FDC lines to HIV‑1 strains. Expression of potential HIV‑1 receptors on FDC lines (a). The bars represent the mean expression 
value and standard deviation for CD21, Siglec 1, CCR5, CXCR4, CD4, DC‑SIGN, β7 and α4 integrins, TAM Axl, TAM Mer and Dtk Mer in 3 FDC lines. 
Data was normalized to the percentage of positive cells detected with the isotype control antibodies. Nested PCR for detection of HIV‑1 RNA and 
proviral DNA (b). The expected PCR product size of 138 bp detected through pol primers JA79‑JA82 and JA80‑JA81 confirmed the infection of FDC 
1401 and 1402 cells with the HIV‑1 strains IIIB and SF162. The upper band visible in the picture represents the amplicon for the outer primers. RNA 
and DNA were prepared from FDCs cells at day 7 post‑exposure. HIV‑1 p24 antigen in culture supernatants from FDC lines 1401, 1402 and 1403 
at 10 days post‑exposure with IIIB and SF 162, as measured by ELISA (c). The cut off OD value is 0.28 and results above this limit where considered 
positive
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In order to further verify the results obtained by micro-
array we used real-time PCR. The results from real-time 
PCR could, to a large extent, verify the microarray results. 
Control and HIV-1 exposed FDCs were studied for the 
expression of pro-inflammatory chemokines including 
CXCL3, CXCL5 and CXCL6 (Fig. 5). These chemokines 
Fig. 3 Kinetics of p24 production in FDC lines exposed to HIV‑1 and intracellular p24 staining. The FDC lines 8–13 and 10–13 were exposed to 
the HIV‑1 strains IIIB and SF162 over‑night. Thereafter the virus was removed from the cultures which were washed extensively with tissue culture 
medium; 6 h following the last washing, the time point 0 was collected. Supernatants were also collected at days 3, 7, 10 and 14. a Detection of 
HIV‑1 p24 protein in culture supernatants at different days of culture. In b detection of p24 intracellular antigen in cell lines 8–13 and 10–13 at 
1 week after exposure to IIIB and SF162 HIV‑1 strains is shown. The p24 positive cells are shown inside the gate on the dot-plots
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were up-regulated in the HIV-1 exposed FDCs; CXCL5 
had a similar expression pattern in both 9.13 and 10.13 
lines while the expression of CXCL3 and CXCL6 in 10.13 
FDCs was higher than in the 9.13 FDC line.
IL-8 expression was up-regulated in HIV-1 exposed 
FDCs with high positive modulation in SF162. In relation 
to IL-4, there was no expression and modulation in any 
line (control and HIV-1 exposed FDCs).
The expression of the chemokines CCL2 and CCL25 
was different in the different HIV-1 exposed lines: the 
10.13 FDC line showed an increased expression for both 
chemokines whereas the opposite pattern was shown for 
the 9.13 FDC line.
Chemo‑attractive activity of FDCs and antigen presenting 
capacity following exposure to HIV‑1 strains
To evaluate the impact that HIV-1 may have on the prop-
erties of FDCs to release chemo-attractants for B and 
T-cells, migration of T and B cells towards cell culture 
supernatant from HIV-1 and medium exposed FDCs was 
evaluated by trans-well migration assay.
PBMCs from three healthy donors were activated for 
2  days with CpG, PHA or the combination of IgM and 
anti-CD40; the activation of B and T cells was monitored 
through the expression of CD69 activation marker (Addi-
tional file 3: Figure S3). Thereafter, the PBMCs were cul-
tured for 4 h in trans-well membrane plates in presence 
Fig. 4 Dysregulated expression of chemokine genes in HIV‑1 exposed FDCs. A summary of the genes whose expression was significantly altered 
in FDCs exposed to either IIIB or SF162 is presented in a. Genes whose expression was significantly (p < 0.05) up‑ or down‑regulated more than 
twofolds are shown in the table. The results are also presented as heat maps (b)
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of supernatant obtained from FDC cultures 7 days post-
HIV-1 exposure. Migration of T and B cells was meas-
ured by counting the migrated cells and subsequent 
calculation (by flow cytometry) of the frequency of B and 
T cells within the migrated cells.
The activation experiment revealed a varying degree 
of CD69 expression (Additional file 3: Figure S3A–C) on 
PBMCs, B and T cells. CPG, PHA and the combination 
of IgM and anti-CD40 were all effective, although to a 
different degree, in upregulating the expression of CD69 
on B cells from three donors (Additional file  3: Figure 
S3B) as the expression of CD69 ranged between 15 and 
82 % for the different activation signals. In T cells, upreg-
ulation of CD69 occurred mostly with PHA (Additional 
file 3: Figure S3C).
The frequency of B and T cells among PBMCs migrat-
ing towards the supernatants from HIV-1 exposed (IIIB 
and SF162) FDC lines is shown in Fig.  6a–f. The fre-
quencies of migrated cells reflected the composition 
of PBMCs; no significant differences in the frequency 
of migrated B and T-cells towards the culture medium 
from HIV-1 exposed FDCs and control supernatant were 
observed (Fig. 6a–f).
The antigen capturing capacity of FDCs is an impor-
tant functional property of these cells; this feature was 
evaluated in FDCs exposed to HIV-1 for 1 day by cultur-
ing cells for 4  h with Alexa Fluor 488 conjugated oval-
bumin. The relative MFI of ovalbumin capturing in cells 
cultured with medium was 0.85 ± 0.07, for IIIB exposed 
cells 0.78 ± 0.15 and for SF162 exposed cells 0.83 ± 0.12. 
These results demonstrated that FDCs exposed to HIV-1 
for 24 h maintained an intact antigen capturing capacity 
(Additional file 4: Figure S4).
Production of inflammatory cytokine by HIV‑1 exposed 
FDCs
The production and secretion of cytokines includ-
ing IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, 
IL-17A, IFN-γ, TNF-α and GM-CSF was evaluated by 
ELISA-array in the culture supernatant of two HIV-1 
exposed FDC lines (1401 and 1402) and non-exposed 
cultures.
Fig. 5 Real‑time PCR of control and HIV‑1 exposed FDC lines. Real‑time PCR was performed to verify the dys‑regulated expression of genes 
revealed by gene array. The genes analysed by RT‑PCR comprise CXCL3, CXCL5, CXCL6, IL‑4, IL‑8, CCL2 and CCL25. The numbers on the y axis show 
the relative number of copies for the chemokine gene. The samples were normalized by quantitation‑relative curve with human beta‑actin
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Fig. 6 Migration of B and T cells towards HIV‑1 exposed FDCs. PBMCs from 3 donors were activated with CpG, PHA or the combination of anti IgM 
and anti CD40 and placed for 4 h on trans‑well chambers containing the supernatant from FDCs (8–13 and 1403) exposed to HIV‑1 (IIIB or SF162 
strain) for 7 days. Cells were also migrated towards medium. The frequency of migrated CD19+ B (a–c) and CD3+ T‑cells (d–f) in total migrated 
cells were measured by Flow cytometry. The data represent the cumulative mean and standard deviation for 3 activation conditions in cells from 3 
donors
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IL-1β, IL-2, IL-4, IL-12, IL-17A, IFN-γ and TNF-α were 
not detectable in the supernatants of either HIV-1 or 
medium exposed FDCs (results not shown). Interestingly, 
the production of the inflammatory cytokines IL-6, IL-8, 
IL-1β and GM-CSF increased in HIV-1 exposed cultures 
(Fig. 7) with GM-CSF and IL-8 increasing mostly. These 
observations indicate that HIV-1 exposure of FDCs can 
induce the production of cytokines involved in inflam-
mation and DC maturation. Interestingly, also the levels 
of production of IL-10, an anti-inflammatory cytokine, 
were elevated in FDC cultures exposed to HIV-1 strains.
In order to study if HIV-1 replication in exposed cul-
tures was essential for production of inflammatory 
cytokines IL-6 and IL-8, we heat-inactivated (56  °C 
for 60  min) the virus strains IIIB and SF162; FDC lines 
8–13 and 10–13 were thereafter exposed to heat-inac-
tivated viruses in parallel with the native virus strains. 
Supernatants from FDCs cultures exposed to native and 
heat-inactivated viruses were collected at 10  days post-
infection and the levels of IL-6 and IL-8 measured. As 
shown in Fig. 8a, b the levels of IL-6 and IL-8 are com-
parable in supernatants from cultures exposed to native 
and heat-inactivated viruses. Although it cannot be 
excluded that replication competent viruses may remain 
in the heat-inactivated virus preparations, the experi-
ment strongly suggests that virus components may have 
a role in inducing production of IL-6 and IL-8 through a 
mechanism which is not yet characterized.
B cells die when co‑cultured with HIV‑1 exposed FDCs
In order to understand the impact that the inflammatory 
environment created by the production of inflammatory 
cytokines from HIV-1 exposed FDCs could have on T and 
B cells we cultured HIV-1 exposed FDCs with PBMCs 
obtained from healthy donors. The FDC lines 1401 and 
1402 were exposed to HIV-1, washed extensively and 
cultured for 2 days before addition of PBMCs from non-
infected donors; these mixed culture of FDCs and PBMCs 
were prolonged for additional 2 and 7  days. Following 
these days of co-culture, the PBMCs were analyzed by 
flow cytometry for viable lymphocytes and frequency of 
B and T-cells, while the cell free culture supernatants were 
used for IgG and IgM detection by ELISA.
The viability of lymphocytes co-cultured with HIV-1 
exposed FDCs was not affected at 2  days of co-culture 
whereas was markedly reduced at 7 days declining from 
83 % in non-exposed cultures to 40 % in IIIB exposed and 
41 % in SF162 exposed FDCs (Fig. 9a).
The frequency of viable CD3+ T cells was not changed 
at either day 2 or 7 when comparing PBMCs cultured with 
control or HIV-1 exposed FDCs (Fig. 9b). The frequency of 
CD19+ cells at day 2 of co-culture was comparable among 
PBMCs cultured with either HIV-1 exposed or medium 
FDCs. On the other hand, the frequency of CD19+ B 
cells was reduced from 3.6  % in the presence of control 
FDC lines to 0.39 % in IIIB and 0.36 % in SF162 exposed 
FDCs 7 days after co-cultivation (Fig. 9c). The frequency of 
Fig. 7 Cytokine production from FDCs upon HIV‑1 infection. The FDC lines 1401 and 1402 were exposed to HIV‑1 strains IIIB and SF162 overnight, 
washed and cultured for 10 days. Cytokines release in supernatant were measured by ELISA array. The data represent the absorbance value of sam‑
ples after subtraction of the value for the negative control
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CD19+ cells among PBMCs cultured for 7 days in absence 
of FDCs was similar to the frequency of B cells among 
PBMCs cultured in presence of control FDCs (3.5  %). 
These results indicate that HIV-1 exposed FDCs may exert 
a pathological specific impact on B cells, by inducing cell 
death in co-cultures of FDC lines and PBMCs.
In order to further dissect the biological relevance of 
these findings we measured the levels of IgG and IgM pro-
duced in culture. Decreased levels of IgG (Fig. 9d) and IgM 
(Fig. 9e) were evident in supernatants obtained, at 7 days, 
from co-cultures of PBMCs with HIV-1 exposed FDCs as 
compared to PBMCs cultured with control FDCs.
Discussion
In spite of successful anti-retroviral therapy (ART), and 
in presence of undetectable viremia in blood, several 
studies have shown that HIV-1 structural proteins and 
glycoproteins persist within the GCs of HIV-1 infected 
patients; it has been suggested that these viral proteins 
may be present in ICs captured by FDCs and be involved 
in the maintenance of long-term humoral immunity to 
HIV-1 in absence of viral replication [28]. When examin-
ing post-mortem material from HIV-1 infected subjects 
Keele and collaborators [29] showed that HIV-1 virus 
trapped on FDCs was infectious and genetically diverse. 
The authors also emphasized the relevance of FDCs as 
reservoirs for HIV-1 infection as, in comparison to other 
cell types which are currently considered as reservoirs 
for HIV-1 infection, FDCs can trap a large amount of 
intact virus particles which can be directly transmitted to 
HIV-1 target cells. These virus particles are maintained at 
the surface of FDCs by HIV-1 antibody captured through 
the presence of high levels of thiol groups and sequestra-
tion of virions in dendritic processes of FDCs. The virus 
complexed at the surface of FDCs can be transmitted to 
several cell types, including T cells and macrophages, the 
latter event taking place through an intercellular commu-
nication network controlled by the P-selectin glycopro-
tein ligand 1 [30].
FDCs are stromal cells located in B cell follicles. They 
have the ability to trap immune complexes and rescue 
B cells from apoptosis. FDC are CD45-negative, express 
CD21, CD23, CD35, CD40, CD44, CD73, ICAM-1, 
VCAM-1, BAFF and MFGE8, and secrete CXCL13 [4, 7]. 
All these characteristics were found in our FDC lines as 
shown in the present paper or in our previous articles [4, 
27, 31]. We also compared FDC lines with fresh isolated 
FDC, and found equivalent antigen phenotypes and func-
tions in both types of cells [31]. The only exception was 
the expression of CD35, which has been detected in fully 
mature FDC, but was not found in our FDC lines (this 
work). This difference suggests that FDC lines consist of 
precursors of FDC (pre-FDC) similar to those reported 
by Krautler et  al. in the mouse [3]. Like our FDC lines, 
these murine pre-FDCs are CD140b+ (PDGFβ) and 
express alpha smooth muscle actin-ASMA [this paper 
(4, 27, 31)]. Although our FDC lines are pre-FDC, they 
display typical FDC functions such as immune complex 
trapping and inhibition of B cell apoptosis [31].
Studies assessing in vitro the infection of FDCs by HIV-1 
have not been previously performed; this is due to the fact 
that FDCs are difficult to isolate from lymphoid tissue as 
they represent only 1 % of the cells within this compart-
ment [4]. Upon these conditions FDC lines were charac-
terized and shown to share morphological and functional 
characteristics with bone marrow stromal cell progenitors 
Fig. 8 Cytokine production from FDC lines exposed to inactivated 
virus. The FDC lines 8–13 and 10–13 were exposed to virus strains IIIB 
and SF162 in their native state and following inactivation at 56 °C for 
60 min. At 10 days from virus exposure, supernatants from FDC cul‑
tures were collected and analyzed for IL‑6 (a) and IL‑8 (b) production
Page 12 of 17Sabri et al. Retrovirology  (2016) 13:61 
and myofibroblasts. Human FDCs have also been shown 
to share similarities with decidual stromal cells (DSCs) 
as both cell types display supportive activity for B cells. 
A recent study also demonstrated that FDCs and DSCs 
showed distinctive features as supporting cells for B lym-
phocytes: both cell types produce BAFF and CXCL13 and 
have the capacity to rescue B cells from apoptotic pro-
cesses [27]. In addition it was shown that both FDCs and 
DSCs are related to mesenchymal stem cells.
Following the many evidences suggesting that HIV-1 
particles do not replicate in FDCs, but carry the virus in 
form of ICs, it has been suggested that FDCs may con-
tribute to late phases of persistent viremia during ART in 
infected patients [32], an event mediated in part by the 
low penetration of ART into lymphatic tissues and allow-
ing for persistent virus replication [33].
In our experiments, the exposure of FDC primary 
lines to HIV-1 isolates did not change the expression of 
molecules which have previously been used to charac-
terize the lineage specificity of these cells [4]. The cells 
expressed low levels of CD4 and of potential HIV-1 
receptors including CD21, Siglec 1, CXCR4 and mem-
bers of the TAM receptor family including TAM Axl, 
TAM Mer and Dtk Mer, which have been suggested as 
alternative receptors for the adhesion of HIV-1 to tar-
get cells. In order to dissect if the multitude of potential 
HIV-1 receptors expressed on the surface of FDCs play a 
role for HIV-1 attachment further studies are needed. It 
is also possible that selected populations of FDCs within 
the FDCs lines used in our experiments may display a 
different degree of sensitivity to HIV-1 attachment and 
infection.
In our experiments, minimal levels of the p24 protein 
could be detected in supernatants from HIV-1 exposed 
FDC cultures; it was however not possible to dissect 
whether the presence of this HIV-1 protein in virus super-
natants could be due to virus production or to trapping of 
virus particles from the initial virus inoculum at the sur-
face of HIV-1 exposed FDCs. It is however unlikely that, 
in absence of specific HIV-1 antibodies, the virus may 
persist for several days trapped at the surface of FDCs.
As by interacting with B and T cells FDCs play a pivotal 
role for the establishment of GCs, we performed experi-
ments to clarify whether exposure of FDCs to HIV-1 
perturbates functions which may be pivotal for the inter-
action between FDCs and B cells including chemotaxis 
and survival. Chemokines are important molecules to 
mediate chemotaxis of cells to functional niches; by using 
Fig. 9 Viability and cell death in lymphocytes co‑cultured with HIV‑1 exposed FDCs. The FDC lines 1401 and 1402 were exposed to HIV‑1 IIIB or 
SF162 o.n., washed and cultured for 2 days before PBMCs from healthy blood donors were added. The viability of lymphocytes was evaluated at 2 
and 7 days of co‑cultivation by Flow cytometry. The data represent the cumulative mean of vivid (a) negative lymphocytes in PBMCs from three 
donors co‑cultured for either 2 or 7 days with FDCs. The viability of T (b) and B (c) cells is presented as cumulative mean and SD of vivid negative 
CD3+ and CD19+ positive cells in PBMCs from three donors co‑cultured for either 2 or 7 days with FDCs. The levels of IgG (d) and IgM (e) in super‑
natants from PBMCs co‑cultured with HIV‑1 exposed and control FDCs for 10 days and measured by ELISA
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microarray and qPCR we could show that the exposure 
of FDCs to distinct HIV-1 isolates increased the gene 
expression of a number of distinct chemokines which are 
important for migration of macrophages and neutrophils 
(CXCL3, CXCL5, CXCL6). However the gene expression 
of chemokines important for attraction of T and B cells to 
FDCs was not altered by the exposure of FDCs to HIV-1 
isolates. This was also confirmed by the equal amount of 
T and B cells, migrating towards cell culture supernatants 
of HIV-1 exposed FDCs following cell activation through 
different stimuli. Accordingly, the exposure of FDC lines 
to HIV-1 did not lead to changes in chemo-attraction of 
T and B cells.
The microarray experiments revealed an increased 
expression of the inflammatory cytokine IL-8 in HIV-1 
exposed FDCs. The increased gene expression of the 
inflammation mediator IL-8 prompted us to measure 
the levels of additional cytokines in the supernatants of 
HIV-1 exposed and non-exposed FDC lines.
Interestingly the levels of several inflammatory 
cytokines including IL-1β, GM-CSF, IL-6 and IL-8 were 
produced to a much larger extent from FDCs exposed to 
virus strains HIV-1 IIIB and SF162 than control cells. The 
production of these inflammatory cytokines may lead to 
various biological mechanisms in cells interacting with 
FDCs in vitro. Increased levels of GM-CSF may acceler-
ate the differentiation of DCs and macrophages locally 
and perturbate the correct differentiation program in 
these cells. Experiments conducted to assess whether the 
production of inflammatory cytokines could be mediated 
by virus components, in addition to native virus strains, 
revealed that heat-inactivated virus was as efficient as 
intact virus in inducing production of the inflamma-
tory cytokines IL-6 and IL-8. The molecular mechanism 
involved in this pathological effect is not clarified but it 
will be important to dissect whether binding of HIV-1 
surface protein gp120 to potential HIV-1 receptors has a 
role for inducing production of inflammatory cytokines 
from FDC lines. According to the results presented by us 
it is likely that virus captured at the surface of FDCs in 
the GCs may act to induce production of inflammatory 
cytokines thus affecting B cells in the close proximity.
Incubation of HIV-1 exposed FDCs with B cells 
resulted in a consistent depletion of B cells in the co-
cultures. It is unlikely that HIV-1 upon these conditions 
may infect B cells as these cells do not express HIV-1 
receptors. It was recently proposed that pyroptosis, a 
form of cell death, could lead to depletion of CD4+ T 
cells during HIV-1 infection [34]. Pyroptosis takes place 
during intense inflammatory conditions mediated by 
pre-inflammatory cytokines, including IL-1β, a cytokine 
which we could detect in supernatants of HIV-1 exposed 
FDCs. It is possible that the high concentration of several 
inflammatory conditions detected in the supernatants 
of HIV-1 exposed FDC cultures may affect the sur-
vival of B cells present in co-culture. It is puzzling that 
B cells may be affected upon this condition without any 
detected effect on T cells present in culture. It is how-
ever important to point-out that a reduction of IgG and 
IgM production took place in co-cultures of B cells with 
HIV-1 exposed FDCs; accordingly the declined number 
of B cells detected upon these conditions translates into 
declined production of Igs and may reflect mechanisms 
operating in  vivo and responsible for reduced levels of 
serological memory.
Conclusions
In conclusion we describe that exposure of FDCs to 
HIV-1, although not leading to clearly detectable virus 
production, results in the increased expression and pro-
duction of inflammatory cytokines. The inflammatory 
environment which develops upon these conditions 
results in impaired survival of B cells. This in vitro model 
suggests that a similar mechanism may take place in vivo 
in the germinal center and result in damage of B cells 
thus contributing to impaired B cell responses during 
HIV-1 infection.
Methods
Isolation and culture of FDC lines
FDC lines were established as previously described [4]. 
Tonsil samples were obtained from patients with tonsil-
litis at the Hospital Universitario Virgen de las Nieves 
(Granada, Spain). The patients (3–10  years old) were in 
complete remission before tonsillectomy. Informed con-
sent was obtained from the parents or guardians of each 
patient. This study was approved by the Comité Ético y 
de Investigación (Ethics and Research Committee) of the 
Hospital Universitario Virgen de las Nieves.
Human tonsils were thoroughly washed in PBS solution 
and cut into small pieces that were finely minced between 
two scalpels in a small volume of RPMI 1640 medium 
supplemented with 100  U/ml penicillin and 50  μg/ml 
gentamicin. In order to increase the release of FDCs from 
tissue, the cell suspension was exposed to 0.25 % trypsin 
and 0.5 mM EDTA (Sigma-Aldrich) for 15 min at 37 °C, 
and the enzymatic reaction stopped by adding cold RPMI 
1640 with 20  % fetal calf serum (FCS). The suspension 
was filtered through gauze and centrifuged at 425×g for 
10 min; the supernatant was discarded and the cell pellet 
was resuspended in RPMI 1640. After centrifugation of 
the cell suspension on Ficoll-Paque (Pharmacia Biotech) 
for 20 min at 600×g, cells were collected from the inter-
face, resuspended in PBS and washed. Cells were cultured 
for 1  h at 37  °C in complete RPMI 1640 supplemented 
with 10 % FCS to allow macrophages and granulocytes to 
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adhere to the flask. Thereafter, cells in suspension were 
washed and incubated in Opti-MEM (minimum essential 
medium; Invitrogen, Grand Island, NY) supplemented 
with 3  % fetal calf serum (FCS), 100  UI/ml penicillin, 
100  µg/ml streptomycin and 0.25  mg/ml amphotericin 
(Sigma-Aldrich). After overnight incubation to allow 
adherent cells to attach to the flask, lymphocytes in 
the supernatant were discarded. The medium was then 
replaced and changed twice a week. After 2–4  weeks, 
adherent cells were morphologically uniform and covered 
the whole surface of the 25 cm2 culture flask. Cells viabil-
ity was determined by trypan blue exclusion before any 
experiments were done. Only preparations with >95  % 
viable cells were used. Six cell lines: 1401, 1402, 1403, 
8–13, 9–13 and 10–13 were used in different sections of 
this study. FDC lines were kept up to 15 in vitro passages. 
As the lines showed similar phenotypical characteristics 
prior and after infection, different cell lines were used for 
the different experiments.
Characterization of FDCs by flow cytometry
FDCs were detached from the culture flask by treatment 
with Trypsin/EDTA at room temperature for 5  min. 
Thereafter the cells were washed once with 5  % FCS/
PBS, resuspended at a density of 106 cells/ml in 5 % FCS/
PBS and incubated with the appropriate mAb for 30 min 
at 4  °C in the dark. After washings the cells were resus-
pended in 0.2 ml 2 % Paraformaldehyde (PFA)/PBS and 
immediately analyzed in a flow cytometer (Becton Dick-
inson, Mountain View, CA, USA) using Cellquest soft-
ware (Becton Dickinson).
The percentage of cells that were positive for the dif-
ferent antigens was calculated by comparison with the 
appropriate isotype control. For indirect labeling, FITC-
labeled goat anti-mouse Ig was added after the first mAb. 
Intracytoplasmic labeling was conducted by fixing the 
FDCs with PermFix (BD Bioscience) for 20 min at 4  °C; 
thereafter the cells were washed with 0.2 ml PermWash 
(BD Bioscience) before adding the mAbs. All analyses 
were evaluated with a FACScan flow cytometer.
The monoclonal antibodies (mAbs) used to charac-
terize the phenotypical characteristics of FDCs were PE 
conjugated anti-CD10, PE anti-CD14, PE anti-CD21, 
FITC anti-CD31, FITC anti-CD35, APC anti-CD44, PE 
anti-CD45, FITC anti-CD54, Alexa Fluor 647 anti-Podo-
planin, PE anti-HLA-DR all from BioLegend (San Diego, 
CA USA); FITC conjugated anti-CD90, PE anti-CD106, 
PE anti-CD140b, APC anti-CD146 and APC anti-Siglec-1 
(CD169) were all from eBioscience (San Diego, CA USA). 
PE conjugated anti-MFGE8, APC anti-CXCL12 and APC 
anti-CXCL13, Alexa Fluor 488 anti-TAM AXI, APC 
anti-TAM Mer and PE anti-Dtk Mer were purchased 
from R&D Bioscience (Minnesota, USA) while APC 
anti-CCR5, PE anti-CXCR4, FITC anti-CD4, APC anti-
DC-SIGN (CD209), APC anti-Integrin β7, PE anti-α4 
(CD49d) and APC anti-CCR5 were from BD Bioscience 
(USA). The FITC conjugated anti-ASMA antibody was 
from SIGMA while the unlabeled anti-CD105 (clone 
P4A4) was a gift from Dr. F.J. Blanco (CIBER de Enferme-
dades Raras, Madrid, Spain). Matched isotype control 
antibodies were included in the stainings. The epitopes 
detected by these mAbs were not affected by the trypsin 
treatment used to detach the cells.
The Alexa Fluor 488 conjugated ovalbumin for antigen 
capture capacity test was from Life Technologies (address 
USA).
HIV‑1 viral stocks and infection
The HIV-1 strains IIIB (CXCR4 user) and SF162 (CCR5 
user) were grown in PHA/IL-2 stimulated lymphocytes 
and clarified supernatant stocks were frozen at −80  °C. 
HIV-1 RNA load was measured by Cobas Amplicor (Roche 
Molecular Systems Inc., Branchburg, New Jersey, USA) 
and was 150 ×  106 copies/ml for both viruses. FDC cul-
tures at about 70 % confluence were washed once with PBS 
and exposed to 1 ml of IIIB or SF162 overnight; cells were 
thereafter washed two times with PBS to remove unab-
sorbed viruses. Fresh OPTI medium from Gibco supple-
mented with 3 % FCS, 50 U/ml penicillin and streptomycin 
was then added to the cells and cultures protracted accord-
ing to the experiments to be conducted. For co-culture with 
PBMCs, FDCs were cultured in 6-well plates and exposed 
to HIV-1 as described above for 2 days. The IIIB virus used 
for infection and its mock preparations were assessed for 
the contents of cytokines GMCSF, IL-1β, IL-6 and IL-10 
with commercial ELISA kits (R&D Minneapolis, USA); the 
concentration of these cytokines did not exceed 0.5 ng/ml.
Blood from healthy donors was the source of PBMCs 
which were prepared by gradient centrifugation and cul-
tured in RPMI 1640 containing 10 % FCS, 50 U/ml peni-
cillin and 50  U/ml streptomycin (HyClonem Thermo 
scientific, Logan, USA). PBMCs were added to FDC 
cultures at the density of 2  ×  106  cells/well. PBMCs 
were collected after one week co-cultivation with HIV-1 
exposed or non-exposed FDCs and the viability and fre-
quency of T and B cells were measured.
LIVE/DEAD® Fixable Near-IR Dead Cell Stain Kit 
from Life Technologies was used to determine viability 
of PBMCs. APC conjugated anti-CD3 and PE anti-CD19 
monoclonal antibodies (BD Bioscience) were used for 
monitoring the frequency of living T and B cells. Cells 
were acquired using LSR II Flow Cytometer (Becton 
Dickinson, San Jose, CA, USA) and analyzed through 
Flow-Jo software version 887 (Three Star Inc., OR, USA).
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For detection of intracellular p24 HIV-1 protein in FDC 
cell lines exposed to either SF162 or IIIB strains, the anti-
p24 antibody KC57-RD1 (Beckman Coulter, Brea, CA, 
USA) was used. Briefly, at 1 week post virus exposure to 
the virus the FDC cells were fixed with 4 % PFA and sub-
sequently stained in Perm/Wash buffer (BD Biosciences, 
San Jose, CA, USA) for 2 h at +4 °C.
The Vironostika HIV-1 Ag/Ab Microelisa system 
(BioMerieux, France), based on a one-step “sandwich” 
principle, was used to detect production of the HIV-p24 
antigen in supernatant of FDCs cells exposed to HIV-1.
Determination of viral RNA and proviral DNA in FDC cells
FDCs were exposed overnight to HIV-1 IIIB and SF162 
strains; thereafter the cells were extensively washed in 
PBS and cultured for additional 7  days until separate 
RNA and DNA preparations were initiated from virus-
exposed and control cells. RNeasy lysis buffer was added 
to the cells for total RNA extraction using RNeasy Mini 
Kit (SA Biosciences, QIAGEN, CA, USA). RNA extrac-
tion was performed according to the manufacturer’s rec-
ommendation. For DNA preparation, FDCs were washed 
twice with PBS prior to lysis. The total DNA was obtained 
using QIAamp DNA Mini kit (SA Biosciences, QIAGEN, 
CA, USA) according to manufacturer’s instructions. 
RNA was also prepared from cell culture supernatants 
obtained at day 0 and day 7. Extracted RNA was used for 
cDNA synthesis using primer JA82 [35, 36] and Thermo-
script (Life Technologies, Stockholm, Sweden) essentially 
according to the instructions of the manufacturer.
HIV-1 proviral DNA and cDNA was diluted in four 
tenfold-steps and PCR amplified in duplicate using 
HIV-1 pol primers JA79-JA82 and JA80-JA81, known to 
amplify diverse genetic subtypes within the HIV-1 group 
M [35, 36]. Lysates from HIV-1 LAI infected cells and 
dH2O were included as positive, respectively negative, 
control for each PCR running. Two independent PCRs 
were performed on two independent cell preparations. 
The amplicons were visualized by GelRed staining after 
electrophoresis in a 1.5 % agarose gel.
PCR microarray for chemokine and chemokine receptors
Human chemokines and chemokine receptors PCR array 
(SA Biosciences, QIAGEN, CA, USA) used in this study 
is designed to analyze 84 chemokines and chemokines 
receptor genes; 4 housekeeping genes were used for nor-
malization of the data.
Non-exposed FDC cells were compared to HIV-1 
exposed cell cultures to study genes differentially 
expressed in HIV-1 IIIB and SF162 exposed FDCs. The 
PCR Array was performed according to manufacturer’s 
instructions. The results were analyzed using RT2 pro-
filer PCR array data analysis version 3.5.
Real‑time PCR
Total RNA from the line FDC 10.13 and FDC 9.13 (con-
trol and HIV-1 exposed) was extracted as described, and 
cDNAs were synthesized. Primers were designed corre-
sponding to the genes found dysregulated in the micro-
array experiments. Each primer was submitted into an 
NCBI BLAST search to ensure specificity for the target 
mRNA (Table 1). The primers were synthesized by Inte-
grated DNA Technologies (San Diego, California, USA).
Real-time RT-PCR was performed under conditions of 
2 min at 50 °C, followed by 10 min at 95 °C, 95 °C 1 min 
and 1 min at 58 °C (CXCL6), 52 °C (CCL2 and CCL25), 
48 °C (CXCL3), 46 °C (IL-4 and IL-8) and 45 °C (CXCL5) 
respectively for 40 cycles. Data were analyzed using AB 
Applied Biosystems 7500 and 7500 Fats Real Time PCR 
Systems version 2.0.1 and were converted into threshold 
cycle (Ct) values. The samples were normalized by quan-
titation-relative curve with human beta-actin.
Migration assay
Cell migration assay was conducted using 24-well insert 
(Costar) with 5-µm pores. PBMCs from normal, healthy 
donors were activated with either CPG-ODN, a synthetic 
TLR9 agonist (Invitrogen), or Phytohemagglutinin (PHA) 
(Sigma) or anti-human IgM (Jackson Immuno Research) 
and anti CD40 monoclonal antibody, clone B-B20 (BioSite).
The activation status of the cells was then investigated by 
measuring CD69 expression on CD19+ and CD3+ PBMCs 
by Flow cytometry prior to migration assay. After 2 days of 
activation, 0.5 × 106 PBMCs were added in the upper insert 
of the migration plates whereas 0.6 ml of supernatant from 
HIV-1 exposed or non-exposed FDCs were added in the 
lower insert. After 4 h at 37 °C, the inserts were removed, 
the cells collected from the lower wells and counted in a 
hemacytometer. Thereafter, the migrated cells were fixed 
with 2 % PFA and the frequency of CD19 and CD3 positive 
cells among migrated cells was evaluated.
The monoclonal antibodies (mAbs) used to identify 
and characterize the PBMCs in the migration assay are 
PE anti-CD69, FITC and PE anti-CD19, APC and FITC 
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anti-CD3, PE and FITC isotype antibodies all purchased 
from BD Bioscience.
Antigen capture assay
HIV-1 exposed FDCs (10-13, 1402 and 1403) were cul-
tured for 24 h at 37 °C and 5 % CO2. After removing the 
virus, cells were washed extensively with PBS and incu-
bated in growth medium supplemented with 1  mg/ml 
Alexa Fluor 488 conjugated ovalbumin for 2 h at 37 °C and 
5 % CO2. Finally cells were washed three times, detached 
from the culture plate by Trypsin–EDTA for 5  min and 
immediately analyzed in a FACSCalibur flow cytometer.
Analysis of culture supernatants
The IgG and IgM production in 7  days’ co-cultures of 
HIV-1 exposed FDCs with PBMCs was measured in cul-
ture supernatants by ELISA. IgG production was ana-
lyzed in culture supernatants by an in-house ELISA, 
using a goat anti-human IgG (H  +  L) (Thermo Fisher, 
Waltham, MA) as capture antibody, a goat anti-human 
IgG conjugated with Horse-Radish-Peroxidase (HRP) 
(Thermo fisher, Waltham, MA) as a secondary antibody 
and the TMB substrate solution (BD Pharmingen). IgM 
levels were analyzed using ELISA a commercial kit from 
Mabtech (Nacka Strand, Sweden).
Supernatants of FDC lines exposed to HIV-1 and cul-
tured for 10 days were screened for 12 human cytokines 
(IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-
17A, IFN-γ, TNF-α, GM-CSF) using the Multi-Analyte 
ELISArray kit (Qiagen) according to the company’s rec-
ommendation. Virus strains IIIB and SF162 inactivated 
at 56 °C for 60 min were used to assess the relevance of 
virus replication in FDC lines for production of cytokines 
IL-6 and IL-8.
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